Apr 2020

ANTG’S THC-DOMINANT CANNABIS FLOWERS NOW LISTED ON THE ARTG FOR EXPORT

ANTG has now listed two new THC-dominant medicinal cannabis strains on the Australian Register of Therapeutic Goods (ARTG). Listing on the ARTG allows our products to be lawfully exported from Australia to overseas patients. We are very proud to have achieved this milestone and diversified the cannabinoid-based medical treatments ANTG can offer patients to meet their individual needs. Our dried THC cannabis flowers are due to be exported to the European Union.

ANTG appoints new Business Operations Manager   Australian Natural Therapeutics […]

READ MORE >

ANTG’s Eve Cannabis product reveals its potential to kill or inhibit cancer cells without impacting normal cells…

READ MORE >

In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >